Every claim.Every source.Every time.

Helixor turns millions of PubMed Central articles into verified, traceable variant evidence — instantly.

Demo coming soon
Scroll to explore

Helixor Turns Millions OfPubMed Central Articles IntoVerified, Traceable VariantEvidence, Instantly.

01 / The Dig

You read the whole paper to find one number in Table S12.

02 / The Spreadsheet

You lost which row that snippet was from.

03 / The Notation

The search returned nothing.

The paper existed. It used a different notation.

c.5266dupC

04 / The Summary

Confident.Unverifiable.Unacceptable.
Source: [unknown]

None of this is negligence. It's the workflow.

Helixor was built to fix the workflow.

What is Helixor

We find the signal. You classify.

See it in action

Search. Filter. Trace to source.

Watch a real search against indexed PubMed Central articles.

app.helixor.io/search
🔒

Features

Built for the rigor curators demand

Multi-notation Search

HGVS coding, protein, rsID, legacy names — search all notation forms simultaneously. Never miss a paper because it used a different format.

c.5266dupC
p.Gln1756Profs
Q1756Pfs*74
rs80357906

Supplement & Table Mining

Tables and supplementary files surface first. The evidence curators need most is often the hardest to find — until now.

Supp. Table S3 ██████ hit
Table 2 · Row 4 ████ hit
Main text · ¶3 ░░░

ACMG Evidence Mapping

Claims categorized by evidence type: PS3 functional, PP1 segregation, PM2 population frequency, and more.

PS3 Functional
PP1 Segregation
PM2 Frequency
PP4 Computational

Context-aware Results

Germline, somatic, mosaic — or "unknown" when the paper doesn't state it. Helixor never guesses.

Germline ✓
Somatic ✓
Unknown — not stated

Smart Alerts

Save a search. Get notified when new PubMed Central papers match your variant.

3 new articles
for BRCA1 c.5266dupC
since yesterday

Filter by Evidence Type

Functional, segregation, frequency, case report — drill down to exactly what you need for classification.

Functional ×
Segregation ×
+ Add filter

Why Helixor

Built on trust, not promises.

Launching at InSight 2026

Singapore

Live demo with real curator workflows. Request early access below.

Built on PubMed Central

Full-text open access

The same trusted source curators already rely on — indexed, structured, and searchable.

100% traceable

No hallucinations

Every displayed claim links to an exact verbatim snippet. No paraphrases. No guesses.

Every hour saved searching
is an hour spent classifying.

Launching at InSight 2026. We'll reach out when your access is ready.